Geode Capital Management
IPCI

Geode Capital Management’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Geode Capital Management’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-180,877
Closed -$43K – 4177
2018
Q4 		$43K Buy
+180,877
New +$111K ﹤0.01% 4017
2018
Q3 		– Sell
-1,376
Closed -$6K – 4160
2018
Q2 		$6K Hold
1,376
– – ﹤0.01% 4063
2018
Q1 		$7K Hold
1,376
– – ﹤0.01% 4040
2017
Q4 		$11K Hold
1,376
– – ﹤0.01% 4009
2017
Q3 		$13K Hold
1,376
– – ﹤0.01% 4031
2017
Q2 		$28K Sell
1,376
-424
-24% -$8.88K ﹤0.01% 4023
2017
Q1 		$45K Buy
1,800
+424
+31% +$10.9K ﹤0.01% 3963
2016
Q4 		$39K Hold
1,376
– – ﹤0.01% 3944
2016
Q3 		$29K Hold
1,376
– – ﹤0.01% 3972
2016
Q2 		$21K Buy
+1,376
New +$25.1K ﹤0.01% 4025

Geode Capital Management's IPCI Position: Q1 2019 in Review

Geode Capital Management sold out of Intellipharmaceuticals International Inc. (IPCI) in Q1 2019, closing a stake of 180,877 shares — an estimated $43K sold.

Geode Capital Management first reported a position in IPCI in Q2 2016 and held it in 10 quarters. The position peaked at $45K in Q1 2017. 0 funds tracked by Wall St. Rank hold IPCI as of Q1 2019.

  • Geode Capital Management reported no remaining Intellipharmaceuticals International Inc. position as of Q1 2019 after selling out during the quarter.
  • Geode Capital Management sold 180,877 Intellipharmaceuticals International Inc. shares in Q1 2019, an estimated $43K.
  • Geode Capital Management first reported a position in Intellipharmaceuticals International Inc. in Q2 2016 and held it in 10 quarters.
  • Geode Capital Management's Intellipharmaceuticals International Inc. position peaked at $45K in Q1 2017.
  • 0 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q1 2019.

Based on Geode Capital Management's 13F filing for Q1 2019, filed 14 May 2019.